|
|
||||||||||||||
|
|
|||||||||||||||
a Miller Children's
Hospital, Long Beach, California and University of California, Irvine,
California, USA, b The Liposome Company, Princeton, New Jersey, USA
Correspondence to: Dr Lieberman, Pediatric Infectious Diseases, Miller Children's Hospital, 2801 Atlantic Ave, PO Box 1428, Long Beach, CA 90801-1428, USA jmlieberman{at}pol.net
Accepted 26 September
2000
This study describes the safety and efficacy of amphotericin B
lipid complex (ABLC) in 11 neonates with systemic
Candida infections. Nine of the 11 improved
clinically, and eight of nine evaluable patients had a mycological cure
with ABLC. Creatinine levels improved or did not significantly change
in eight of the 11 patients.
This article has been cited by other articles:
![]() |
C. C. Blyth, P. Palasanthiran, and T. A. O'Brien Antifungal Therapy in Children With Invasive Fungal Infections: A Systematic Review Pediatrics, April 1, 2007; 119(4): 772 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Clerihew, T L Lamagni, P Brocklehurst, and W McGuire Invasive fungal infection in very low birthweight infants: national prospective surveillance study Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2006; 91(3): F188 - F192. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Holler, S. A. Omar, M. D. Farid, and M. J. Patterson Effects of Fluid and Electrolyte Management on Amphotericin B-Induced Nephrotoxicity Among Extremely Low Birth Weight Infants Pediatrics, June 1, 2004; 113(6): e608 - e616. [Abstract] [Full Text] |
||||
![]() |
N. Linder, G. Klinger, I. Shalit, I. Levy, S. Ashkenazi, G. Haski, O. Levit, and L. Sirota Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations J. Antimicrob. Chemother., October 1, 2003; 52(4): 663 - 667. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| ARCH DIS CHILD | FETAL NEONATAL ED | ED PRACTICE |